Daniell Lab Explores Novel Plant-Based Approach to GLP-1 Delivery 

Research led by Penn Dental’s Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as a new oral delivery of two GLP-1 drugs previously approved by the FDA in injectable form. Read article »